Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0998
+0.0006 (0.60%)
Oct 15, 2025, 3:07 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 121.77 million as of October 15, 2025. Its market cap has decreased by -49.34% in one year.
Market Cap
121.77M
Enterprise Value
139.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 121.77M, a decrease of -84.13%. That is a compound annual growth rate of -51.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 122.51M | -47.47% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,659.84B |
| Coloplast | 128.35B |
| Genmab | 127.85B |
| Demant | 47.72B |
| ALK-Abelló | 46.98B |
| H. Lundbeck | 43.22B |
| Zealand Pharma | 34.74B |
| Ambu A/S | 27.09B |